Globus Medical Inc Stock News

Globus Medical (GMED) reports strong fourth-quarter sales growth amid currency headwinds and lingering COVID-19 impacts.

Globus Medical, Inc. (NYSE:GMED ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations

Globus Medical (GMED) delivered earnings and revenue surprises of 7.27% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Globus and NuVasive agreed to merge in a deal that will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share (or $3.1B). Globus shares sold off sharply, as the Street cle

The implied price for NuVasive under terms of the deal is $57.72 a share.

Globus Medical GMED, -1.18% said Thursday it will pay 0.75 a share of its stock for each share of NuVasive NUVA, -2.41% stock in a deal that values NuVasive at about $3.1 billion or $57.72 a share. Gl

AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year

Investors are optimistic about Globus Medical's (GMED) robust performance across several international markets.

Globus Medical's long-term revenue is expected to grow at a CAGR of low double-digits driven by the company's advanced musculoskeletal solutions. The company's INR platform is its primary growth engin

As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?

Globus Medical is positioned to deliver tremendous EPS upside over the coming 3 quarters in our estimation. We are sizing up our long-term position with a buy at $73, confident GMED will hit this poin

Globus showed reacceleration and share growth in the U.S. spine market in the third quarter, as technology (robotics, imaging/navigation) continues to drive implant share growth. There's room for spin

Globus Medical, Inc. (NYSE:GMED ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Da

AUDUBON, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September